sulfadoxine has been researched along with Embryopathies in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (42.86) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 3 (42.86) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abellana, R; Cot, M; Moya-Alvarez, V | 1 |
Boudova, S; Cohee, LM; Joshi, S; Kalilani-Phiri, L; Kamiza, S; Laufer, MK; Makwakwa, K; Mawindo, P; Muehlenbachs, A; Mukadam, R; Seydel, KB; Taylor, TE; Thesing, P | 1 |
Chaluluka, E; Feng, G; Meshnick, SR; Molyneux, ME; Rogawski, ET; Rogerson, SJ | 1 |
Blanc, B; Boubli, L; Casta, M; Chagnon, C; Cravello, L; D'Ercole, C; Franck, J; Harle, JR; Leclaire, M | 1 |
Caxton-Martins, AE; Uche-Nwachi, EO | 1 |
Pinon, JM; Quereux, C; Villena, I | 1 |
Berrebi, A; Bessières, MH; Bloom, MC; Cassaing, S; Courjault, C; Rolland, M; Roques, C; Séguéla, JP | 1 |
1 review(s) available for sulfadoxine and Embryopathies
Article | Year |
---|---|
Pregnancy-associated malaria and malaria in infants: an old problem with present consequences.
Topics: Adult; Africa South of the Sahara; Antimalarials; Comorbidity; Complement Activation; Developmental Disabilities; Drug Combinations; Drug Resistance; Female; Fetal Diseases; Fetal Growth Retardation; Genetic Predisposition to Disease; HIV Infections; HLA-G Antigens; Humans; Immune Tolerance; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Infectious Disease Transmission, Vertical; Malaria; Malaria, Cerebral; Parasitemia; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Infectious; Pyrimethamine; Risk Factors; Stillbirth; Sulfadoxine | 2014 |
6 other study(ies) available for sulfadoxine and Embryopathies
Article | Year |
---|---|
Submicroscopic malaria infection during pregnancy and the impact of intermittent preventive treatment.
Topics: Adult; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Asymptomatic Diseases; DNA, Protozoan; Drug Administration Schedule; Drug Combinations; Drug Resistance; Erythrocytes; Ethanolamines; False Negative Reactions; Female; Fetal Diseases; Fluorenes; Follow-Up Studies; Hemeproteins; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Malaria; Malawi; Parasitemia; Placenta; Plasmodium; Polymerase Chain Reaction; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Pregnancy Trimesters; Prevalence; Pyrimethamine; Quinine; Sulfadoxine | 2014 |
The effects of malaria and intermittent preventive treatment during pregnancy on fetal anemia in Malawi.
Topics: Anemia, Neonatal; Antimalarials; Cross-Sectional Studies; Drug Combinations; Female; Fetal Blood; Fetal Diseases; Hemoglobins; Humans; Infant, Newborn; Malaria; Malawi; Odds Ratio; Parasitemia; Pregnancy; Pregnancy Complications, Parasitic; Prevalence; Pyrimethamine; Regression Analysis; Risk Factors; Sulfadoxine | 2012 |
Recurrent congenital toxoplasmosis in a woman with lupus erythematosus.
Topics: Adult; Amniotic Fluid; Animals; Anti-Infective Agents; Antibodies, Protozoan; Female; Fetal Diseases; Humans; Immunoglobulin G; Immunoglobulin M; Infant, Newborn; Lupus Erythematosus, Systemic; Prednisolone; Pregnancy; Pregnancy Complications; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine; Toxoplasma; Toxoplasmosis, Congenital | 1995 |
Sulfadoxine-pyrimethamine embryopathy in Wistar rats.
Topics: Animals; Antimalarials; Drug Combinations; Embryo, Mammalian; Female; Fetal Diseases; Folic Acid Deficiency; Pregnancy; Pyrimethamine; Rats; Rats, Wistar; Sulfadoxine | 1998 |
Congenital toxoplasmosis: value of prenatal treatment with pyrimethamine-sulfadoxine combination.
Topics: Anti-Infective Agents; Antiprotozoal Agents; Female; Fetal Diseases; Humans; Pregnancy; Pyrimethamine; Sulfadoxine; Toxoplasmosis, Congenital | 1998 |
Neonatal screening for congenital toxoplasmosis in a cohort of 165 women infected during pregnancy and influence of in utero treatment on the results of neonatal tests.
Topics: Animals; Antibodies, Protozoan; Antiprotozoal Agents; Cohort Studies; Female; Fetal Blood; Fetal Diseases; Humans; Immunoglobulin A; Immunoglobulin M; Infant, Newborn; Neonatal Screening; Placenta; Pregnancy; Pregnancy Complications, Infectious; Prenatal Diagnosis; Pyrimethamine; Spiramycin; Sulfadoxine; Toxoplasma; Toxoplasmosis, Congenital | 2001 |